1.90
0.03 (1.6%)
0.03 (1.6%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Millendo Therapeutics Inc | MLND | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.03 | 1.6% | 1.90 | 19:30:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.92 | 1.87 | 1.93 | 1.88 | 1.87 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.90 | 1.92 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,413 | 386,530 | $ 1.90 | $ 733,984 | 719,616 | 1.20 - 9.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:56:54 | formt | 200 | $ 1.90 | USD |
Millendo Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 36.10M | 19.00M | 18.89M | $ - | $ - | -3.26 | -0.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 12.60% |
Millendo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MLND Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.82 | 1.93 | 1.73 | 1.83 | 504,959 | 0.08 | 4.4% |
| 1 Month | 2.27 | 2.33 | 1.56 | 1.75 | 901,529 | -0.37 | -16.3% |
| 3 Months | 1.49 | 2.33 | 1.42 | 1.79 | 505,292 | 0.41 | 27.52% |
| 6 Months | 1.82 | 2.33 | 1.42 | 1.79 | 498,011 | 0.08 | 4.4% |
| 1 Year | 7.89 | 9.88 | 1.20 | 2.23 | 742,433 | -5.99 | -75.92% |
| 3 Years | 10.1567 | 17.34 | 1.20 | 2.67 | 376,542 | -8.26 | -81.29% |
| 5 Years | 10.1567 | 17.34 | 1.20 | 2.67 | 376,542 | -8.26 | -81.29% |
Millendo Therapeutics Description
| Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. Its lead asset, livoletide, is an unacylated ghrelin analogue being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disease characterized by hyperphagia, a chronic unrelenting hunger, that leads to obesity, metabolic dysfunction, reduced quality of life and early mortality. The company is also developing nevanimibe, an ACAT1 inhibitor for the treatment of two orphan adrenal diseases: classic congenital adrenal hyperplasia (CAH) and endogenous Cushing's syndrome (CS). |
